Risk factors for severe sepsis in secondary peritonitis.

BACKGROUND The incidence and risk factors for severe sepsis (SS, organ failure associated with infection) in the context of peritonitis are not well established; thus, it is not clear which patients require more aggressive operative or pharmacologic intervention. We set out to determine risk factors for severe sepsis in a large cohort of patients with intra-abdominal infection. METHODS Patients admitted for peritonitis over a four-year interval were identified using a Washington State administrative hospital discharge database. This cohort was identified by ICD-9 CM diagnoses and diagnosis-related group (DRG) assignment. Patients with organ failure were identified by ICD-9 CM diagnoses codes using a previously validated classification scheme. Independent risk factors for SS were identified using stepwise Poisson regression. RESULTS A total of 11,202 patients with peritonitis were identified, 11% of whom developed SS. The crude relative risk of death in patients with SS was 13 (95% CI, 11.1-15.2) times greater than those without. Severe sepsis was present in 424 (62%) of the 686 decedents. Multivariate analysis showed that source of infection, extent of peritonitis, increasing age, and pre-existing organ dysfunction were independently associated with SS. CONCLUSIONS Severe sepsis complicates the course of 11% of all patients with peritonitis. Risk factor analysis identifies a subset of patients at greatest risk for severe sepsis. These are the patients who should be targeted for evaluation of novel pharmacologic interventions or more aggressive surgical intervention.

[1]  John C. Marshall Intra-abdominal infections. , 2004, Microbes and infection.

[2]  J. Birkmeyer,et al.  Adjusting surgical mortality rates for patient comorbidities: more harm than good? , 2002, Surgery.

[3]  E. Abraham,et al.  Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia , 2002, Journal of leukocyte biology.

[4]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[5]  M. Malangoni,et al.  Prospective Randomized Trials Affect the Outcomes of Intraabdominal Infection , 2001, Annals of surgery.

[6]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[7]  M. Büchler,et al.  Conservative surgical treatment of diffuse peritonitis. , 2000, Surgery.

[8]  M. Wichmann,et al.  Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome , 2000, Intensive Care Medicine.

[9]  A. Algra,et al.  Prognostic scoring systems to predict outcome in peritonitis and intra‐abdominal sepsis , 1997, The British journal of surgery.

[10]  S. Bhagwanjee,et al.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. , 1997, Critical care medicine.

[11]  D. Bates,et al.  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997, JAMA.

[12]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[13]  Miinchen,et al.  Prediction of outcome using the Mannheim peritonitis index in 2003 patients , 1994 .

[14]  J. Jollis,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. , 1993, Journal of clinical epidemiology.

[15]  C. Ohmann,et al.  Prospective evaluation of prognostic scoring systems in peritonitis. Peritonitis Study Group. , 1993, The European journal of surgery = Acta chirurgica.

[16]  J. Bohnen,et al.  APACHE II score and abdominal sepsis. A prospective study. , 1988, Archives of surgery.

[17]  I. Sayek,et al.  Validation of MPI and PIA II in two different groups of patients with secondary peritonitis. , 2001, Hepato-gastroenterology.